Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FTKQR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,712
Award facts
- Contract value 100% obligated
- $1,712.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml auto-injectors. This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a specific product draw against DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award carries no set-aside designation, allowing the vendor to compete on an open basis despite its woman-owned small business status. Performance will take place at the vendor's Park Ridge, Illinois facility.
DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract with the Defense Logistics Agency valued at $499,999,999 through November 2026 under the SPE2DB program, which authorizes firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. This delivery order for Xolair auto-injectors exemplifies the company's role as a critical supplier within the federal pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The vendor has maintained a robust portfolio of pharmaceutical product deliveries to DLA since its SAM.gov registration in 2001, establishing itself as a dependable provider of specialized pharmaceutical products including auto-injectors, injectable medications, and other clinical supplies.
Quick answers
Who was awarded contract SPE2DB25FTKQR?
SPE2DB25FTKQR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FTKQR worth?
The government has obligated $1,712 on SPE2DB25FTKQR.
Is contract SPE2DB25FTKQR an order under another contract?
Yes. SPE2DB25FTKQR is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKQR competed?
The extent of competition for SPE2DB25FTKQR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award